Consumer Information for: ZOLEDRONIC ACID FOR INJECTION
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
Zoledronic Acid for Injection is used to:
1) reduce the abnormal amount of calcium in the blood for example,
in the presence of a tumour. This is because tumours can accelerate
normal bone change in such a way that the release of calcium from
bone is increased. This condition is known as tumour-induced
hypercalcaemia.
2) prevent or delay skeletal complications for example, fractures of
the bone and bone pain requiring surgery or radiotherapy, as a result
of bone metastases (cancer that has spread from the tumour to the
bone) due to different types of tumours.
What it does
Zoledronic Acid for Injection is a member of a group of substances called bisphosphonates. These strongly bind to the bone and slow down the rate of bone change. In addition, Zoledronic Acid for Injection may prevent bone destruction and uncontrolled bone growth associated with the tumour spreading to the bone.
When it should not be used
You should not be given Zoledronic Acid for Injection if you are:
- pregnant
- breastfeeding
- allergic to zoledronic acid, other bisphosphonates (the group of substances to which Zoledronic Acid for Injection belongs) or to any other non medicinal ingredients in Zoledronic Acid for Injection.
- hypocalcaemic (have low calcium levels in your blood)
What the medicinal ingredient is
Zoledronic acid.
What the non-medicinal ingredients are
Mannitol, Sodium Citrate and Water for Injection.
What dosage form it comes in
Zoledronic Acid for Injection is available as a concentrate in vials. Each vial of Zoledronic Acid for Injection delivers 4 mg of zoledronic acid. It is available in cartons containing 1 vial.
Warnings and precautions
Serious Warnings and Precautions
Serious side effects which have been reported with the use of Zoledronic Acid for Injection include:
- osteonecrosis of the jaw (a severe bone disease that affects the jaw)
- deterioration in renal function. Zoledronic Acid for Injection is not recommended in patients with severe kidney impairment.
- hypocalcaemia (low calcium levels in your blood)
If you are being treated with Zoledronic Acid for Injection, you
should not be treated with another intravenous form of
zoledronic acid (i.e. Aclasta®) or other bisphosphonates (e.g.
alendronate, risedronate, clodronate, etidronate and pamidronate)
at the same time.
Your doctor may request an oral examination (an examination of
your mouth and teeth) before you start treatment and while you
are on treatment with Zoledronic Acid for Injection. This may be
required since some patients have experienced serious side
effects following dental procedures (such as tooth extraction)
while on Zoledronic Acid for Injection; as well, since patients
with unhealed open wounds in the mouth, dental infections or
periodontal disease (disease affecting the surrounding tissues of
a tooth) may be at increased risk of problems with their jaw
bones following dental procedures (such as tooth extraction)
while on treatment with Zoledronic Acid for Injection.
You should avoid invasive dental procedures during your
treatment with Zoledronic Acid for Injection. It is important that
you practice good dental hygiene, routine dental care, and have
your regular dental check-ups while being treated with
Zoledronic Acid for Injection. Immediately report any oral
symptoms (any symptoms in your mouth), such as loosening of a
tooth, pain, swelling, or non-healing of sores or discharge (pus
or oozing) during your treatment with Zoledronic Acid for
Injection.
BEFORE you use Zoledronic Acid for Injection talk to your doctor or pharmacist if you:
- Have a kidney problem. Worsening of kidney function, including kidney failure (very rarely with fatal outcome), has been reported with the use of zoledronic acid.
- Have asthma and are also allergic to acetylsalicylic acid (ASA).
- Had or have a heart problem. Cases of irregular heart beat (atrial fibrillation) have been observed with the use of zoledronic acid.
- Have any dental problems or any dental procedures planned in the future.
- Have pain, swelling or numbness of the jaw, a “heavy jaw feeling”, loosening of a tooth, or any other symptoms in your mouth
- Have sores in your mouth. This can lead to
osteonecrosis of the jaw. Your doctor may check if
you:
- smoke
- have or have had tooth and/or gum disease
- have dentures that do not fit well
- have other medical conditions at the same time, such as: low red blood cell count (anaemia) or if your blood cannot form clots in the normal way
Your doctor may tell you to stop taking Zoledronic Acid for
Injection until all sores in your mouth are healed.
After starting treatment with Zoledronic Acid for Injection
It is important that your doctor checks your progress at regular
intervals. He or she may want to take repeated blood tests,
especially after starting your treatment with Zoledronic Acid for
Injection.
If possible, you should not undergo tooth extraction or any other
dental procedures (excluding regular dental cleaning) while you
are receiving treatment with Zoledronic Acid for Injection. Please
consult your doctor if a dental procedure (excluding regular dental
cleaning) is required while you are receiving treatment with
Zoledronic Acid for Injection. It is important to maintain good
dental hygiene; regularly scheduled dental examinations are
recommended.
Tell your doctor if you had or have joint stiffness, aches and
pains and difficulty in movement of your thighs, hips, upper
arms (in the bones between your shoulders and elbows), lower
legs (in the long large bones between your knees and your feet),
ribs, backbone, knees, or feet bones (in the five long bones
between your ankles and your toes), or pain around your ears.
Tell your doctor, as this may be a sign of bone damage due to
loss of blood supply to the bone (osteonecrosis).
Driving and using machines
Zoledronic Acid for Injection may affect your ability to drive a
car or to operate machinery. Do not drive a car or operate
machinery until you know how Zoledronic Acid for Injection
affects you.
Use in Children
Zoledronic Acid for Injection should not be used in children
Interactions with this medication
Tell your doctor about any other medicines you are taking or have
recently been taking, including any you have bought without a
prescription. It is particularly important that your doctor knows if
you are also taking aminoglycosides (a type of medicine used to
treat severe infections), calcitonin (a type of medicine used to treat
high calcium levels in the blood and Paget’s disease), loop
diuretics (a type of medicine used to treat high blood pressure or
oedema) or other calcium-lowering medicines, since the
combination of these with bisphosphonates may cause the
calcium level in the blood to become too low. Examples of
aminoglycosides include gentamycin sulfate, tobramycin sulfate
and streptomycin sulphate; examples of loop diuretics include
furosemide, torsemide and ethacrinic acid.
It is also important to inform your doctor if you are taking any
drugs that can have an effect on the kidney, since combining
these drugs with Zoledronic Acid for Injection may cause kidney
function to deteriorate. Some examples of these drugs include
aminoglycosides, acetylsalicylic acid (ASA), nonsteroidal antiinflammatories (e.g. ibuprofen, diclofenac, celecoxib), diuretics
(e.g. hydrochlorothiazide, amiloride, spironolactone and
indapamide) and Angiotensin-Converting Enzyme (ACE)
inhibitors (e.g. enalapril, ramipril, fosinopril).
Tell your doctor if you are taking anti-angiogenic medicines (type
of medicines used to treat cancer, e.g. thalidomide, bortezomid,
lenalidomide, bevacizumab) as part of your cancer treatment
because the combination of these medicines with bisphosphonates
may increase the risk of bone damage in the jaw (osteonecrosis).
Proper use of this medication
Usual Dose:
Zoledronic Acid for Injection is given by an infusion into a vein
which should last no less than 15 minutes. The dose is usually 4
mg. If you have a kidney problem, your doctor may give you a
lower dose depending on the severity of your kidney problem.
If you are being treated for multiple myeloma or bone metastases
of solid tumours, you will be given one infusion of Zoledronic Acid
for Injection every three to four weeks. If you require
antineoplastic therapy (therapy that blocks the growth of cancer
cells), Zoledronic Acid for Injection should be administered either
prior to or after this treatment. You will also be asked to take an
oral calcium supplement of 500 mg and a multivitamin containing
at least 400 IU of Vitamin D daily. If you have a prior history of
high levels of calcium in the blood or develop high levels of
calcium in the blood during treatment with calcium and Vitamin D,
you may be advised to discontinue taking calcium and Vitamin D
supplements by your doctor.
Your doctor will decide how many infusions you need and how
often you should receive them.
If you are being treated for Tumour-Induced Hypercalcaemia
(TIH), you will normally only be given one infusion of Zoledronic
Acid for Injection. Prior to treatment with Zoledronic Acid for
Injection, restoring and maintaining adequate fluid regulation in
your body and urine output may help to eliminate excess calcium
from your kidneys.
Overdose:
If you think you have taken too much Zoledronic Acid for Injection, contact your health care professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. You may develop serum electrolyte abnormalities and changes in kidney function, including severe kidney impairment.
Side effects and what to do about them
Like all medicines, Zoledronic Acid for Injection may have, in
addition to its beneficial effects, some unwanted effects. These are
usually mild and will probably disappear after a short time. The
most common side effect is short-lasting fever. Patients may
experience a flu-like condition including fever, fatigue, weakness,
drowsiness and chills. In some patients, these symptoms may also
be accompanied by bone, joint and/or muscle ache, arthritis and
joint swelling. In most cases, no specific treatment is required and
the symptoms subside after a couple of hours or days. Other
common side effects include gastrointestinal problems such as
nausea, vomiting and thirst as well as swelling of sores inside the
mouth and loss of appetite.
Occasionally, skin reactions (redness and swelling) at the infusion
site may occur. Cases of low blood pressure have also
occasionally been reported; in very rare cases, this resulted in
fainting.
Rare cases of rash, itching, chest pain, swelling mainly of the face
and throat, high level of potassium and sodium in the blood, slow
heartbeat, confusion and a disorder of the kidney function called
Fanconi syndrome have been observed.
Very rare cases of severe bone, joint, and/or muscle pain,
occasionally incapacitating, as well as sleepiness, irregular heart
beat (atrial fibrillation), difficulty breathing with wheezing or
coughing, lung disease, severe allergic reaction and itchy rash
have also been reported.
Reduced levels of calcium in the blood (hypocalcaemia),
sometimes leading to muscle cramps, dry skin or burning
sensation, have been reported in patients treated with zoledronic
acid. Irregular heart beat has also been reported. There have been
reports of abnormal electrical signals of the heart called
“prolongation of the QT interval”, seizures, numbness, spasm and
twitching caused by severely reduced levels of calcium in the
blood. In some instances, the reduced calcium level may be lifethreatening and require hospitalization. If any of these apply to
you, tell your doctor right away.
Blood tests indicating worsening of kidney function (higher levels
of creatinine) including severe kidney failure have been reported
with zoledronic acid; such changes are also known to occur with
other drugs of the bisphosphonate class. Your doctor will carry
out blood tests to monitor your kidney function prior to each dose
of Zoledronic Acid for Injection. If these tests indicate worsening
of kidney function, your doctor will withhold further treatment
with Zoledronic Acid for Injection until these tests have returned
to normal.
The level of calcium, phosphate and/or magnesium in the blood
may become too low, but your doctor will monitor this and take
necessary measures.
Other bisphosphonates can cause breathing difficulties in patients
with asthma who are allergic to acetylsalicylic acid (ASA). This
has not been reported with zoledronic acid, in studies done to date.
Eye pain, redness, photophobia (sensitivity to light), excessive
tearing or decreased vision should be reported to your physician
as they may indicate more serious eye complications which have
been associated with zoledronic acid.
Some patients have reported problems with their jaw bones while
receiving cancer treatments that include zoledronic acid. Dental
hygiene is an important element of your overall cancer care and is
important in possibly decreasing the chances of this type of
problem occurring. Removable dentures should fit properly and
should be removed at night. Please consult with your doctor if you
experience pain in your mouth, teeth or jaw, or if your gums or
mouth heals poorly. Any non-healing of a dental extraction site or
chronic dental infection should be reported and assessed. In
addition, if possible you should not undergo tooth extraction or
other dental procedures (excluding regular dental cleaning) while
on therapy with Zoledronic Acid for Injection. Please consult your
doctor if a dental procedure (excluding regular dental cleaning) is
required while you are receiving treatment with Zoledronic Acid
for Injection.
Some patients have reported problems with other bones, other
than their jaw bones, while on treatment with Zoledronic Acid for
Injection. Consult your doctor if you had or have aches and pains
and difficulty in movement of your thighs, hips, upper arms, lower
legs, ribs, backbone, knees, or feet bones, or if you experience
pain around your ears.
Unusual fracture of the thigh bone may occur while receiving
treatment with Zoledronic Acid for Injection. Contact your doctor
if you experience pain, weakness or discomfort in your thigh, hip
or groin as this may be an early sign of a possible fracture of the
thigh bone.
Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
Common | |||
Worsening of kidney function higher levels of creatinine) | ✔ | ||
Bone, joint and/or muscle pain, joint stiffness | ✔ | ||
Conjunctivitis | ✔ | ||
Uncommon | |||
Kidney failure (changes in urine colour or absence of urine production, changes in kidney function laboratory tests, lower back pain, fatigue, nausea, loss of appetite) | ✔ | ||
Eye disorders (painful red and/or swollen eye, excessive tearing, light sensitivity, or decreased vision) | ✔ | ||
Allergic reaction to zoledronic acid (swelling of the face, eyes or tongue, difficulty breathing, hives, rash, sudden onset of low blood pressure) | ✔ | ||
Dizziness | ✔ | ||
Osteonecrosis of the jaw (numbness or feeling of heaviness in the jaw, poor healing of the gums especially after dental work, loose teeth, exposed bone in mouth, pain in the mouth, teeth or jaw, sores or non-healing sores in the mouth or discharge (pus or oozing), swelling, dry mouth, swelling, gum infections, or bad breath) | ✔ | ||
Osteonecrosis of other bones (joint stiffness, aches and pains, and difficulty in movement of the thighs, hips, upper arms, lower legs, ribs, backbone, knees, or feet bones, or pain around the ears) | ✔ | ||
Unknown | |||
Difficulty breathing with wheezing or coughing | ✔ | ||
Irregular heart beat (atrial fibrillation) | ✔ | ||
Sleepiness | ✔ | ||
Severe allergic reaction | ✔ | ||
Itchy rash | ✔ | ||
Thigh pain, weakness of or discomfort/Unusual fracture of the thigh bone | ✔ | ||
Muscle cramps or twitching, dry skin, burning sensation, or irregular heartbeat | ✔ | ||
Disorder in kidney function with release of amino acids, phosphate and glucose in urine (acquired Fanconi syndrome) | ✔ |
The frequency with which these side effects may occur cannot be
reliably estimated.
This is not a complete list of side effects. If you have any
unexpected effects after receiving Zoledronic Acid for
Injection, contact your doctor or pharmacist.
How to store
Vials (concentrate)
Store Zoledronic Acid for Injection vials at room
temperature (between 15°C - 30°C).
Zoledronic Acid for Injection must be kept out of reach and sight
of children and pets.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about Zoledronic Acid for Injection:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; or by contacting the manufacturer, Juno Pharmaceutical Corp: 1-855-819-0505.
This leaflet was prepared by:
Juno Pharmaceuticals Corp.
402-2233 Argentia Road
Mississauga, Ontario
L5N 2X7
Last revised: September 22, 2020
ACLASTA® and AREDIA® are registered trademarks.
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
ARIDOL | 02489562 | PHARMAXIS EUROPE LIMITED | MANNITOL 5 MG / CAP MANNITOL 10 MG / CAP MANNITOL 20 MG / CAP MANNITOL 40 MG / CAP |